Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity
- 1 April 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 320, 32-44
- https://doi.org/10.1016/j.jconrel.2020.01.017
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81603035, 81873662, 81870599)
- China Postdoctoral Fellowship (2018T110986)
This publication has 46 references indexed in Scilit:
- Targeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamineJournal of Controlled Release, 2013
- Characterization of CD44-Mediated Cancer Cell Uptake and Intracellular Distribution of Hyaluronan-Grafted LiposomesMolecular Pharmaceutics, 2011
- Targeting kidney mesangium by nanoparticles of defined sizeProceedings of the National Academy of Sciences of the United States of America, 2011
- Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cellsAdvanced Drug Delivery Reviews, 2010
- Renal fibrosis: novel insights into mechanisms and therapeutic targetsNature Reviews Nephrology, 2010
- Endocytosis of nanomedicinesJournal of Controlled Release, 2010
- The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agentsBiomaterials, 2010
- Biomimetic amplification of nanoparticle homing to tumorsProceedings of the National Academy of Sciences of the United States of America, 2007
- Renal fibrosis: New insights into the pathogenesis and therapeuticsKidney International, 2006
- Serum Enzyme Determinations in the Diagnosis and Assessment of Myocardial InfarctionCirculation, 1972